<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02244073</url>
  </required_header>
  <id_info>
    <org_study_id>2013.808</org_study_id>
    <secondary_id>2013-A00806-39</secondary_id>
    <nct_id>NCT02244073</nct_id>
  </id_info>
  <brief_title>Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.</brief_title>
  <acronym>CONTROLING</acronym>
  <official_title>Individualized Blood Glucose Control in ICU.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the last 2 decades, the management of hyperglycemia in critically ill patients has
      become one of the most discussed topics in the intensive-care field. The initial data
      suggesting significant benefit from the normalization of blood glucose levels in critically
      ill patients using intensive intravenous insulin therapy (Van den Berghe G et al. N Engl J
      Med. 2001) has been tempered by later studies (Finfer S et al. N Engl J Med. 2009). Some
      studies suggested that strict blood glucose control might benefit in non-diabetic patient and
      worsen outcomes in diabetics. We hypothesized that an individualized blood glucose target
      based on glycated hemoglobin measured at ICU admission would improve outcome when compared to
      a standard care of maintaining blood glucose bellow 10 mmol/l (180 mg/dl). We designed a
      randomized double blinded study in which Blood glucose control is piloted in both groups by a
      web-guided protocol that directly gives instruction to nurses
      (https://extranet.chu-lyon.fr/cpg). The study will enroll 4200 patients in 10 centers.
      Primary end point is 90 d outcome after randomization.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Data safety monitoring board decision
  </why_stopped>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>90 days after randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>28 days after randomization and at ICU discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of intensive care unit stay</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for respiratory support, vasopressor support, dialysis and non-prophylactic antibiotics</measure>
    <time_frame>during ICU stay (on average 10 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence and severity of severe hypoglycemia (less than 2.2 mmol/l)</measure>
    <time_frame>during ICU stay (on average 10 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2069</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Individualized blood glucose target</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maintain blood glucose in individualized target based on glycated hemoglobin level (A1c); Blood glucose level is maintained bellow 1.59 × A1c - 1.59 (mmol/l).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional blood glucose target</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Maintain blood glucose bellow 10 mmol/l.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Human insulin - Insulin administration to control blood glucose level.</intervention_name>
    <description>On ICU admission, the glycated hemoglobin level (A1c) is measured and insulin IV is possibly administered using a web based nurse driven insulin infusion protocol (https://extranet.chu-lyon.fr/cpg) to maintain blood glucose level below 10 mmol/l. Glycated hemoglobin result triggers patient randomization. Thereafter, during ICU stay, blood glucose level is maintained either below 1.59 × A1c - 1.59 (mmol/l) (Individualized blood glucose target group), or bellow 10 mmol/l (Conventional blood glucose target group).</description>
    <arm_group_label>Individualized blood glucose target</arm_group_label>
    <arm_group_label>Conventional blood glucose target</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients are eligible for INCLUSION in the study if ALL the following criteria are met:

          -  Patient is 18 year old or older;

          -  At time of the patient's admission to the ICU the treating ICU specialist expects the
             patient will require treatment in the ICU that extends beyond the calendar day
             following the day of admission.

        Exclusion Criteria:

          -  Patients will be EXCLUDED from the study if ONE or MORE of the following criteria are
             present:

               -  Patient or legal surrogate decision maker does not accept the participation to
                  the study;

               -  Imminent death (anticipated in less than 48 hours);

               -  The treating clinicians are not committed to full supportive care (no
                  resuscitation, no renal replacement therapy limits in dose of vasoactive
                  support);

               -  Patient is expected to be eating before the end of the day following admission;

               -  Admission in ICU for hypoglycemic encephalopathy or patient at risk for
                  hypoglycaemia ( e.g. known insulin secreting tumour or history of unexplained or
                  recurrent hypoglycaemia or fulminant hepatic failure);

               -  If a patient has previously been enrolled in the CONTROLING Study (patients
                  cannot be enrolled in the CONTROLING Study more than once).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien BOHE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Nord Franche Comte</name>
      <address>
        <city>Belfort</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Bourg-en-Bresse</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>01012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bourgoin-Jallieu</name>
      <address>
        <city>Bourgoin Jallieu</city>
        <zip>38302</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Chartres</name>
      <address>
        <city>Chartres</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont Ferrand - Gabriel Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon - Complexe Hospitalier du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpital de l'Archet 1</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Polynésie Française</name>
      <address>
        <city>Papeete</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Salon de Provence</name>
      <address>
        <city>Salon de Provence</city>
        <zip>13658</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Saint Etienne - Hôpital Nord</name>
      <address>
        <city>St Priest en Jarez</city>
        <zip>42277</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2014</study_first_submitted>
  <study_first_submitted_qc>September 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2014</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood glucose target</keyword>
  <keyword>ICU</keyword>
  <keyword>insulin</keyword>
  <keyword>hypoglycemia</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>glycated hemoglobin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

